ACE Inhibitors or ARBs for Prediabetics?; Xigris is Approved for Severe Sepsis; ACE Inhibitors Inhibiting Aortic Valve Stenosis?; FDA Actions
Treatments for Acute Migraine; Statin Therapy for ACS Patients; The Correct Dosing for Onychomycosis; FDA Actions
Authors: William J. Kennedy, DO, Fellow, Palliative Care Services, Mount Carmel Health, Columbus, OH; Philip H. Santa-Emma, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH; and Robert M. Taylor, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH. Peer Reviewer: Lynn McDonald, MD, Medical Director, Hospice of Kankakee Valley, Bourbonnais, IL.
The nationwide push for infection rate disclosure laws is an historic opportunity to get full funding for clinically proven surveillance methods in the nations hospitals, one of the modern pioneers in the field said recently in Baltimore at the annual meeting of the Association for Professionals in Infection Control and Epidemiology (APIC).
With increasing demands for infection rate data and public accountability, infection control professionals are finding that the public has very little understanding of the ICPs role in the hospital.
